RE:RE:SPR competition JuiceLee wrote: SUMKNDV1DERFL wrote: No mention of SPR, but fun article to read. Interesting forecast of extraction market. On a side note. Sure SPR could use funds in direct internal growth such as JV or alike. However, I don’t believe placing resources into PR is a mismanagement of funds as Hawk continues to allude to. All companies do it and they do it for good reason. PR is accounted for in a balanced business budget. Enjoy the read as you keep SPR in mind/comparison to the companies mentioned and extraction forecasted.
:-)
Keth Dolo mentions this in an interview, he knows that Canada MJ is mainly retail investors and talks about how its important to keep them informed and excited so this was part of the plan.
I am suprised some of you still even mention some peoples names as they do not have the same goal as the longs do and he will grab onto anything he can to stay relevant in your posts.
You are just encouraging him saying his name and making him a part of your point. He is winning and you are losing. Please stop mentioning him as I blocked him and he still gets through, through you guys.
More emulsification but still, more products planned. I'm starting to think SPR gave away too much to Moosehead.
Valens, Iconic Brewing sign five-year deal to develop cannabis-infused drinks
Cannabis extractor
Valens GroWorks announced a deal with Toronto-based Iconic Brewing Company to develop pot-infused beverages together. The deal will see Valens provide cannabis extracts, formulation services, and emulsification for the upcoming lineup of cannabis-infused beverages, while Iconic will brand and market the final product across Canada. Terms of the agreement state the companies will develop a minimum of 2.5 million cannabis-infused beverages over the next five years. Financial terms were not disclosed.
Ryan Macdonell, an analyst with GMP Securities, said in a note to clients the deal could represent $8.75 million in total sales, assuming a sale price of $3.50 per beverage, with Valens generating up to $1.5 million of revenue. More deals for Valens are expected after the company said in previous statements it is currently negotiating over 50 white label opportunities, Macdonell said.